RhondaJBurke
New
Is it appropriate to continue to code morbid obesity for patients who are currently being treated with GLP-1 medications and have a measured reduction in BMI from 40+ to below 35? There continues to be active treatment for the diagnosis with medication, along with routine assessment & monitoring.